BLB&B Advisors’s Sanofi SNY Stock Holding History

BLB&B Advisors’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-5,573	Closed	-$240K	–	317
2017 Q4	$240K	Buy	5,573 +1,500	+37%	+$69.2K	0.03%	264
2017 Q3	$203K	Sell	4,073 -100	-2%	-$4.84K	0.03%	281
2017 Q2	$200K	Sell	4,173 -300	-7%	-$14.3K	0.03%	266
2017 Q1	$202K	Buy	+4,473	New	+$190K	0.03%	270
2015 Q4	–	Sell	-4,468	Closed	-$212K	–	282
2015 Q3	$212K	Sell	4,468 -76	-2%	-$3.87K	0.05%	257
2015 Q2	$225K	Sell	4,544 -174	-4%	-$8.82K	0.05%	245
2015 Q1	$233K	Hold	4,718	–	–	0.05%	242
2014 Q4	$215K	Buy	4,718 +145	+3%	+$7.04K	0.05%	259
2014 Q3	$258K	Hold	4,573	–	–	0.06%	239
2014 Q2	$243K	Sell	4,573 -100	-2%	-$5.31K	0.05%	248
2014 Q1	$244K	Hold	4,673	–	–	0.05%	245
2013 Q4	$251K	Sell	4,673 -600	-11%	-$31K	0.06%	223
2013 Q3	$267K	Sell	5,273 -150	-3%	-$7.63K	0.07%	208
2013 Q2	$279K	Buy	+5,423	New	+$289K	0.08%	194

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BLB&B Advisors's SNY Position: Q1 2018 in Review

BLB&B Advisors sold out of Sanofi (SNY) in Q1 2018, closing a stake of 5,573 shares — an estimated $240K sold.

BLB&B Advisors first reported a position in SNY in Q2 2013 and held it in 14 quarters. The position peaked at $279K in Q2 2013. 487 funds tracked by Wall St. Rank hold SNY as of Q1 2018.

BLB&B Advisors reported no remaining Sanofi position as of Q1 2018 after selling out during the quarter.
BLB&B Advisors sold 5,573 Sanofi shares in Q1 2018, an estimated $240K.
BLB&B Advisors first reported a position in Sanofi in Q2 2013 and held it in 14 quarters.
BLB&B Advisors's Sanofi position peaked at $279K in Q2 2013.
487 funds tracked by Wall St. Rank held Sanofi as of Q1 2018.

Based on BLB&B Advisors's 13F filing for Q1 2018, filed 9 Apr 2018.